½ÃÀ庸°í¼­
»óǰÄÚµå
1321046

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ¶óÀ̺귯¸® Áغñ ÀÚµ¿È­ ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø(2017-2027³â)

Next Generation Sequencing Library Preparation Automation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product, By Sequencing Type, By Application, By End User, By Company and By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 114 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Áغñ ÀÚµ¿È­ ½ÃÀåÀº 2023-2027³âÀÇ ¿¹Ãø ±â°£ µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ´Ù¾çÇÑ Áúº´ÀÇ ¹ßº´·ü Áõ°¡, Â÷¼¼´ë ½ÃÄö½Ì¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈ÷°í ÀÖ½À´Ï´Ù. Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS)Àº ´ë¿ë·®, È®À强, ºü¸¥ ¼Óµµ·Î ÀüÀå À¯Àüü ¿°±â¼­¿­À» ±¸ÃàÇÒ ¼ö ÀÖ´Â º´·Ä ó¸® ±â¼úÀÔ´Ï´Ù. Â÷¼¼´ë ½ÃÄö½Ì(NGS)Àº »ùÇà Àüó¸®, ¶óÀ̺귯¸® Áغñ, ½ÃÄö½Ì, »ý¹°Á¤º¸ÇÐ µîÀÇ ´Ü°è¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ¶óÀ̺귯¸® Áغñ °úÁ¤Àº NGS ¿öÅ©Ç÷ο쿡¼­ ¸Å¿ì Áß¿äÇÏÁö¸¸, ¼Ò·®ÀÇ ÇÇÆêÆÃÀ» ³ôÀº Á¤È®µµ·Î ¼öÇàÇØ¾ß Çϱ⠶§¹®¿¡ ¿©·¯ ´Ü°è¸¦ ¹Ýº¹ÇØ¾ß ÇÏ°í ½Ã°£ÀÌ ¸¹ÀÌ °É¸³´Ï´Ù. ¶óÀ̺귯¸® ÁغñÀÇ ÀÚµ¿È­´Â È¿À²¼ºÀ» ³ôÀ̰í, º¸´Ù ¾ÈÁ¤ÀûÀÎ °á°ú¸¦ »ý¼ºÇϸç, ½ÇÇè½ÇÀÇ È¿À²¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ´Ù¸¥ ¿äÀÎÀ¸·Î´Â ±¤¹üÀ§ÇÑ Á¶»ç °³¹ß, ¼ö¸¹Àº ÀÓ»ó½ÃÇè, ÀÎÁöµµ Çâ»ó, ´Ù¾çÇÑ Á¤ºÎ ÅõÀÚ, ¶óÀ̺귯¸® Áغñ ÇÁ·ÎÅäÄÝÀ» ±¸ÃàÇϱâ À§ÇÑ ±â¾÷ °£ Çù·Â Áõ°¡, ±â¼ú ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù.

Â÷¼¼´ë ½ÃÄö½Ì¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

Â÷¼¼´ë ½ÃÄö½Ì(NGS)Àº DNA ¹× RNA ½ÃÄö½Ì°ú µ¹¿¬º¯ÀÌ °ËÃâÀ» »ç¿ëÇÏ´Â ±â¼úÀÔ´Ï´Ù. ´Ü½Ã°£¿¡ ¼öõ °³ÀÇ À¯ÀüÀÚ¿Í °Ô³ðÀ» ½ÃÄö½ÌÇÒ ¼ö Àֱ⠶§¹®¿¡ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, NGS¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀǾàǰ, ³ó¾÷ ¿¬±¸, ½Å¾à °³¹ß, À¯ÀüüÇÐ, ¾Ï, µ¿¹° ¿¬±¸ µî ´Ù¾çÇÑ ¿ëµµ·Î Ȱ¿ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ºñ¾Ïȣȭ RNA, Àü»ç ÀÎÀÚÀÇ °áÇÕ ºÎÀ§ ½Äº°, ¸®½ÃÄö½Ì¿¡µµ »ç¿ëµË´Ï´Ù. NGS´Â Á¤È®Çϰí È¿À²ÀûÀ̸ç ÷´Ü ½Ã½ºÅÛ°ú Àú·ÅÇÑ ºñ¿ëÀ¸·Î ÀÎÇØ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2018³â ¹Ì±¹ ¸ÞµðÄÉ¾î ¹× ¸ÞµðÄÉÀÌµå ¼­ºñ½º ¼¾ÅÍ(CMS)´Â ¾ÏÀ» Áø´ÜÇϱâ À§ÇØ NSG °Ë»ç¸¦ ½ÃÇàÇÏ´Â ±¹°¡ Àû¿ë °áÁ¤À» ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ, ½Äǰ ¾ÈÀü ¹× ǰÁú¿¡ ´ëÇÑ Â÷¼¼´ë ½ÃÄö½ÌÀÇ »ç¿ëÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÅõÀÚ ¹× ¿¬±¸°³¹ß Ȱµ¿ Áõ°¡

Á¤ºÎ¿Í ÁÖ¿ä ½ÃÀå ±â¾÷µéÀº ´Ù¾çÇÑ R&D Ȱµ¿¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖÀ¸¸ç, 2022³â ±¹¸³º¸°Ç¿¬±¸¿øÀÇ »ý¸í°øÇп¡ ´ëÇÑ ÃÑ À¶ÀÚ ±Ô¸ð´Â 7Á¶ 9,120¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. Á¦¾àȸ»ç¿Í »ý¸í°øÇÐ ±â¾÷µéÀº ÁÖ·Î ÀǾàǰ °³¹ß °úÁ¤ÀÇ ÇÙ½ÉÀÎ ¿¬±¸°³¹ß(R&D)¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ßÀÇ Á߿伺Àº ÀǾàǰ ½ÂÀÎ °Ç¼ö°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡¿¡¼­ µÎµå·¯Áý´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â FDAÀÇ ÀǾàǰÆò°¡¿¬±¸¼¾ÅÍ(CDER)´Â 53°³ÀÇ ½Å¾àÀ» ÀÎÁõÇß°í, 2019³â¿¡´Â 48°³ÀÇ ½Å¾àÀ» ½ÂÀÎÇß½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â 2022³â ¸»±îÁö °úÇÐ ¿¬±¸ °³¹ßÀÇ ¼öÀÍÀÌ 81¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ¶ÇÇÑ ¿¬±¸°³¹ß¿¡¼­ NGS Ȱ¿ëÀ» °­È­ÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê°¡ Áõ°¡Çϰí Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2018³â È£ÁÖ Á¤ºÎ´Â 20¸¸ ¸íÀÇ Âü°¡ÀÚ¸¦ ½ÃÄö½ÌÇÏ´Â Genomics Health Futures Mission¿¡ 10³â°£ 3¾ï 7,200¸¸ ´Þ·¯ÀÇ ÅõÀÚ¸¦ ¼±¾ðÇß½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

¼¼°è Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Áغñ ÀÚµ¿È­ ½ÃÀåÀº Á¦Ç°, ½ÃÄö½Ì À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× ±â¾÷À¸·Î ºÐ·ùµË´Ï´Ù. Á¦Ç°À» ±âÁØÀ¸·Î ½ÃÀåÀº ŰƮ¿Í ¼Ò¸ðǰ, Àåºñ·Î ³ª´¹´Ï´Ù. ½ÃÄö½Ì À¯Çü¿¡ µû¶ó ½ÃÀåÀº DNA ½ÃÄö½Ì°ú RNA ½ÃÄö½ÌÀ¸·Î ³ª´¹´Ï´Ù. ¿ëµµº°·Î ½ÃÀåÀº Áø´Ü°ú °úÇÐ ¿¬±¸·Î ³ª´¹´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡ µû¶ó Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷, ÀÓ»ó ¹× Áø´Ü ½ÇÇè½Ç, Çмú ¹× ¿¬±¸ ±â°ü, ±âŸ·Î ³ª´¹´Ï´Ù. ±¹°¡º°·Î´Â ¹Ì±¹ÀÌ À¯Àü¼º Áúȯ Áõ°¡¿Í ±¤¹üÀ§ÇÑ ±â¼ú °³¹ß·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È À¯¸®ÇÑ ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ±â¾÷

Agilent Technologies, Inc. Hamilton Company, Hologic Inc., Illumina Inc., Oxford Nanopore Technologies Limited, PerkinElmer, Inc, QIAGEN NV´Â ÀÌ ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

»ç¿ë °¡´ÉÇÑ Ä¿½ºÅ͸¶ÀÌ¡

TechSci Research´Â ÁÖ¾îÁø ½ÃÀå µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿© ±â¾÷ÀÇ °íÀ¯ÇÑ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÈ­ÇÒ ¼ö ÀÖ´Â ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. º¸°í¼­´Â ´ÙÀ½°ú °°Àº Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´ÉÇÕ´Ï´Ù.

±â¾÷ ¼Ò°³

  • Ãß°¡ ½ÃÀå ÁøÃâ±â¾÷(ÃÖ´ë 5°³»ç)¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼® ¹× ÇÁ·ÎÆÄÀϸµ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Á¶Á¦ ÀÚµ¿È­ ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå °í°´ÀÇ ¼Ò¸®

Á¦6Àå ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Á¶Á¦ ÀÚµ¿È­ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ¸ÅÃ⺰
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç°º°
    • ½ÃÄö½Ì À¯Çüº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±â¾÷º°
    • Áö¿ªº°
  • ½ÃÀå ¸Ê

Á¦7Àå ºÏ¹ÌÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Á¶Á¦ ÀÚµ¿È­ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ¸ÅÃ⺰
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç°º°
    • ½ÃÄö½Ì À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ºÏ¹Ì ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦8Àå À¯·´ÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Á¶Á¦ ÀÚµ¿È­ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ¸ÅÃ⺰
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç°º°
    • ½ÃÄö½Ì À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • À¯·´ ±¹°¡º° ºÐ¼®
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Á¶Á¦ ÀÚµ¿È­ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ¸ÅÃ⺰
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç°º°
    • ½ÃÄö½Ì À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ

Á¦10Àå ³²¹ÌÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Á¶Á¦ ÀÚµ¿È­ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾× ±âÁØ
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç°º°
    • ½ÃÄö½Ì À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Â÷¼¼´ë ½ÃÄö½Ì(NGS) ¶óÀ̺귯¸® Á¶Á¦ ÀÚµ¿È­ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ¸ÅÃ⺰
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç°º°
    • ½ÃÄö½Ì À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA) : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ÅÍŰ
    • ÀÌÁýÆ®

Á¦12Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦13Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦14Àå °æÀï ±¸µµ

  • Agilent Technologies, Inc.
  • BGI Group
  • Aurora Biomed Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F.Hoffmann-La Roche AG
  • Eppendorf SE
  • Hamilton Company
  • Hologic Inc.
  • Illumina Inc.
  • Oxford Nanopore Technologies Limited
  • PerkinElmer, Inc.
  • Promega Corporation
  • Takara Bio Inc.
  • QIAGEN NV

Á¦15Àå Àü·«Àû Á¦¾È

LSH 23.08.23

The global next-generation sequencing (NGS) library preparation automation market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing incidences of various diseases, rising demand for next-generation sequencing, and a rise in government initiatives, which are curbing the market's growth. Next-generation Sequencing (NGS) is a parallel processing technology that can establish the sequence of nucleotides in a whole genome with ultra-high capacity, scalability, and high speed. Next-generation sequencing (NGS) includes steps such as sample pre-processing, library preparation, sequencing, and bioinformatics. The library preparation process is crucial in NGS workflow but is very time-consuming due to the several repetitive steps requiring small volumes to be pipetted with high accuracy. The automation of library preparation can enhance efficiency, produce more steady results, and improve lab efficacy. The other factors supporting the market's growth are the extensive research and development, the large number of clinical trials, increasing awareness, various government investments, the growing number of collaborations between companies to build library preparation protocols, and technological advancements.

Rising demand for Next Generation Sequencing

Next-generation sequencing (NGS) is a technique that uses DNA and RNA sequencing and mutation detection. It sequences thousands of genes or genomes in a shorter time, which surges the demand for its usage. Growing demand for NGS is fueling the growth of the market. This is attributed to the wide range of applications such as personalized medicines, agricultural research, drug discovery, genomics, cancer, and animal research. It is also used for non-coding RNA, identification of binding sites on transcriptional factors, and resequencing. Owing to its accurate, efficient, and advanced system, along with low costs, the rise in demand for NGS is bolstering the growth of the market. For instance, in 2018, the Centers for Medicare & Medicaid Services (CMS) stated the National Coverage Determination to carry out NSG tests to diagnose cancer. In addition, the use of next-generation sequencing in food safety and quality is propelling the market's growth.

Increasing Investments and R&D Activities

Governments and key market players invest in various R&D activities, which augments the market's growth. In 2022, total biotechnology financing by the National Institutes for Health was USD 7,912 billion. Pharmaceutical and biotechnology companies majorly focus on research and development (R&D), a core part of drug development processes. The significance of R&D is noticeable due to the growing number of drug approvals. For instance, in 2020, the FDA's Center for Drug Evaluation and Research (CDER) certified 53 novel drugs, whereas 48 were approved in 2019. In the U.S., the revenue in scientific R&D is likely to amount to USD 8.11 billion by the end of 2022. Also, the rise in initiatives by governments to enhance the use of NGS in R&D and continuous innovation and advancements in technology are driving the growth of the market. For instance, in 2018, the Australian government declared an investment of $372 million for over 10 years in its Genomics Health Futures Mission to sequence 200,000 contestants.

Market Segmentation

The global next-generation sequencing (NGS) library preparation automation market is segmented into product, sequencing type, application, end-user, and company. Based on product, the market is divided into kits and consumables, and instruments. Based on sequencing type, the market is divided into DNA sequencing and RNA sequencing. Based on application, the market is segmented into diagnostics and scientific research. Based on end users, the market is divided into pharmaceutical & biotechnology companies, clinical & diagnostic laboratories, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to an increase in occurrences of genetic diseases and extensive technology development in the country.

Market Players

Agilent Technologies, Inc., BGI Group, Aurora Biomed Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, Eppendorf SE, Hamilton Company, Hologic Inc., Illumina Inc., Oxford Nanopore Technologies Limited, PerkinElmer, Inc., Promega Corporation, Takara Bio Inc., and QIAGEN NV are some of the leading companies operating in the market.

Report Scope

In this report, the global next generation sequencing (NGS) library preparation automation market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Next Generation Sequencing (NGS) Library Preparation Automation Market, By Product:

  • Kits and Consumables
  • Instruments

Next Generation Sequencing (NGS) Library Preparation Automation Market, By Sequencing Type:

  • DNA Sequencing
  • RNA Sequencing

Next Generation Sequencing (NGS) Library Preparation Automation Market, By Application:

  • Diagnostics
  • Scientific Research

Next Generation Sequencing (NGS) Library Preparation Automation Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Clinical & Diagnostic Laboratories
  • Academic & Research Institutions
  • Others

Next Generation Sequencing (NGS) Library Preparation Automation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global next-generation sequencing (NGS) library preparation automation Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Next Generation Sequencing (NGS) Library Preparation Automation Market

5. Voice of Customer

6. Global Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Kits and Consumables v/s Instruments)
    • 6.2.2. By Sequencing Type (DNA Sequencing v/s RNA Sequencing)
    • 6.2.3. By Application (Diagnostics v/s Scientific Research)
    • 6.2.4. By End User (Pharmaceutical & Biotechnology Companies, Clinical & Diagnostic Laboratories, Academic & Research Institutions, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Market Map

7. North America Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Sequencing Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Sequencing Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Sequencing Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Sequencing Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Sequencing Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Sequencing Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Sequencing Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Sequencing Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Sequencing Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Sequencing Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Sequencing Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Sequencing Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Sequencing Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Sequencing Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Sequencing Type
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Sequencing Type
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Sequencing Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Sequencing Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Sequencing Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Sequencing Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Sequencing Type
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Sequencing Type
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Sequencing Type
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Sequencing Type
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Turkey Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Sequencing Type
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User
    • 11.3.5. Egypt Next Generation Sequencing (NGS) Library Preparation Automation Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product
        • 11.3.5.2.2. By Sequencing Type
        • 11.3.5.2.3. By Application
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Agilent Technologies, Inc.
  • 14.2. BGI Group
  • 14.3. Aurora Biomed Inc.
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Danaher Corporation
  • 14.6. F.Hoffmann-La Roche AG
  • 14.7. Eppendorf SE
  • 14.8. Hamilton Company
  • 14.9. Hologic Inc.
  • 14.10. Illumina Inc.
  • 14.11. Oxford Nanopore Technologies Limited
  • 14.12. PerkinElmer, Inc.
  • 14.13. Promega Corporation
  • 14.14. Takara Bio Inc.
  • 14.15. QIAGEN NV

15. Strategic Recommendations

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦